Data from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic

MLA

Eva Szabo, et al. Data from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4fa3f75d71d704b4a7f8b8484b2f7389&authtype=sso&custid=ns315887.

APA

Eva Szabo, Caroline C. Sigman, Samir N. Khleif, Gary J. Kelloff, Olivera Finn, Ronald B. Herberman, Gary Gordon, Dean E. Brenner, Gregory A. Curt, & Frank L. Meyskens. (2023). Data from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic.

Chicago

Eva Szabo, Caroline C. Sigman, Samir N. Khleif, Gary J. Kelloff, Olivera Finn, Ronald B. Herberman, Gary Gordon, Dean E. Brenner, Gregory A. Curt, and Frank L. Meyskens. 2023. “Data from Regulatory Approval of Cancer Risk-Reducing (Chemopreventive) Drugs: Moving What We Have Learned into the Clinic,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........4fa3f75d71d704b4a7f8b8484b2f7389&authtype=sso&custid=ns315887.